CD BioGlyco. news
CD BioGlyco, a leading provider in the field of glycoproteomics, has recently updated its Glycoprotein Quantification Service. This enhancement aims to offer more precise and comprehensive glycoprotein analysis, catering to the growing demands in the fields of biomedical research, disease biomarker discovery, and therapeutic development.
Protein glycosylation, a major post-translational modificat
CD BioGlyco, a biotechnology company dedicated to developing a one-stop service in the field of glycomics, now provides professional and high-quality glycan derivatization services to give scientific assistance for researchers in need.
Carbohydrates only absorb light at low wavelengths, which makes UV and fluorescence detection less sensitive. Additionally, low sensitivity in glycan analysis is a d
CD BioGlyco, a worldwide biotechnology company, recently released a comprehensive list of lectin products, covering lectin, lectin buffers, lectin kits, lectin antibodies, lectin-coated microplates, as well as lectin columns, which can be served as robust tools for glycoproteins and carbohydrates study.
Lectin refers to a glycoprotein or sugar-binding protein purified from various plants, invertebrates a
CD BioGlyco, a biotechnology company that provides multi-omics analysis of cancer cell glycolysis including genomics, proteomics, metabolomics and metabolic fluxomics, now offers analysis of glycolytic enzymes in cancer cells, enabling thorough understanding of cancer cell glycolysis pathways.
The capacity of cancer cells for aerobic glycolysis is 20–3
CD BioGlyco, a biotechnology company that provides a full range of glycobiology-related products, analysis, custom synthesis, and design to advance glycobiology research, recently released custom thioglycoside synthesis service to provide necessary scientific assistance for worldwide researchers.
Thioglycosides are glycosides in which sulfur atoms have replaced the oxygen atoms. They have received a lot of
CD BioGlyco, a leader in glycosylation characterization, recently developed a comprehensive glycoproteomics platform to provide its customers worldwide with the characterization of glycosylation in protein drugs.
Glycoproteins, such as glycosyltransferases, glycosidases, erythropoietin, and cytokines, make up the majority of biotherapeutic products. Although the drugs themselves
CD BioGlyco, a biotechnology company specialized in the field of glycobiology, has developed a series of advanced vaccine development platforms by integrating various advanced technologies to promote the development of glycol-based vaccines.
Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 are critical in viral attachment and cell fusion, and investigation of these proteins may provide valuable insights into their potential use in vaccines and antiviral strategies. The i
CD BioGlyco, a biotechnology company that provides glycobiology-related products, analysis, custom synthesis, and design to advance glycobiology research, recently announced the release of separation of Separation of Glycosaminoglycans service to the science community.
Glycosaminoglycans, once known as mucopolysaccharides, are mainly found in the connective tissues of higher animals and plants. Glyc
CD BioGlyco, a biotechnology company that provides a full range of glycobiology-related products, analysis, custom synthesis and design to customers worldwide, recently introduced its HMOs separation and analysis services for the healthcare industry.
Human milk is the best food for newborns and developing infants, and its unique function is irreplaceable by other dairy products. Human milk oligosaccharides (HMOs)
CD BioGlyco, a biotechnology company that provides a full range of glycobiology-related products, analysis, custom synthesis, and design to help advance glycobiology research, recently released a glyco-engineered mammalian cell expression system to help scientists with their research.
New biotherapeutic glycoproteins, such as recombinant monoclonal antibodies (mAbs), have